New hormonal agent may slow progression of early-stage prostate cancer during active surveillance
byWolters Kluwer HealthPositive biopsy-free survival with 95% confidence limits (shaded gray areas). Credit:Journal of Urology(2023). DOI: 10.1097/JU.0000000000003038For men with ear
Updated on: January 12,2024
10
New hormonal agent may slow progression of early-stage prostate cancer during active surveillance
byWolters Kluwer HealthPositive biopsy-free survival with 95% confidence limits (shaded gray areas). Credit:Journal of Urology(2023). DOI: 10.1097/JU.0000000000003038For men with ear
Updated on:January 12,2024
10
